Sino Biological launches 4RISE wet-lab service for AI-designed binders

Sino Biological has launched 4RISE™, a high-throughput wet-lab validation service for AI-designed protein binders. The company says the service combines cell-free protein expression, binding analysis and real-time API access to structured data.
- 4RISE™ is a high-throughput wet-lab validation service for AI-designed protein binders.
- Sino Biological says cell-free expression can be completed within 3 hours.
- The workflow provides AI-ready binding data in as little as 3 days.
- Real-time API access is available for structured target-binding data.
- The service includes four validation workflows and additional bioactivity and cell-based assays.
From protein sequence to binding data
Sino Biological said its 4RISE™ service is designed to validate whether AI-developed protein binders show activity against their intended targets. The service includes cell-free expression within 3 hours, AI-enabled binding data in as little as 3 days and real-time API access to structured target-binding data.
The workflow uses Sino Biological’s XPressMAX™ Cell-Free Protein Synthesis platform to produce recombinant proteins. According to the company, expression success rates exceed 99% in established workflows. The platform supports miniproteins, VHHs, scFvs, Fabs, enzymes and cytokines, allowing researchers to test different AI-designed protein formats.
For binding analysis, 4RISE™ uses Carterra High-Throughput SPR, Biacore SPR and Octet BLI. These technologies support high-throughput binding screening, kinetic analysis and affinity measurement. Sino Biological says the combined workflow can provide sequence-to-AI-ready binding data in 3 days.
Four workflows for binder validation
4RISE™ offers four screening and characterization workflows aimed at different stages of AI-assisted binder discovery. Rapid Hit Discovery identifies binding-positive miniproteins and VHHs by screening crude supernatants. Comparative Binder Screening evaluates purified candidates under standardized conditions to support candidate prioritization.
Affinity & Kinetic Characterization provides quantitative binding information for lead selection. Specialized Binder Expression & Validation supports different binder formats through tailored mammalian expression and binding analysis.
The service also extends beyond binding measurements. Sino Biological lists more than 20 development assays, more than 1,000 protein bioactivity assays and more than 10 cell-based functional assays for deeper candidate evaluation and design optimization.
Why the service matters for AI drug discovery
AI-designed molecules still require experimental validation to show whether their predicted properties hold up in the laboratory. By combining rapid expression with high-throughput binding measurements and structured data access, 4RISE™ is intended to give life sciences researchers faster feedback for subsequent design iterations.
Sino Biological said it has worked with AI companies on laboratory validation projects involving AI-assisted antibody development, binder design and protein engineering. The company also said 4RISE™ validation has supported studies published in Science, Nature Communications, Scientific Reports and other high-impact journals.
“AI-designed molecules need reliable experimental evidence from the laboratory to demonstrate their potential,” said Dr. Rob Burgess, managing director at Sino Biological US, according to the company. He said the integrated capabilities are intended to help researchers assess candidates quickly, shorten development cycles and move promising discoveries toward real-world applications.


